• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Lung Cancer

UCLA Research Uses Saliva to Detect Cancer Biomarkers

by Syed Hamza Sohail 07/27/2022 Leave a Comment

UCLA Health’s COVID-19 Swab Shortage Solved With 3D-Printed Swabs

What You Should Know: - Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry that successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva. - Specifically, amplified EGFR mutations associated with non-small cell lung cancer (NSCLC) using Spectrum’s saliva collection and preservation system with the Electric
Read More

$3.7 Trillion Reasons to Centralize Chronic Disease Management

by Ty Vachon M.D., Cofounder at Oatmeal Health 07/13/2022 Leave a Comment

3.7-Trillion-Reasons-to-Centralize-Chronic-Disease-Management

59% of all Americans (194 million) suffer from at least one chronic disease, and almost one in three adults has three or more chronic conditions.  Unfortunately, the problem will only get worse with time.  On the business front of chronic disease management, health care systems are already struggling with rising costs and uneven quality despite the hard work of well-intentioned, well-trained clinicians.  Health care leaders and policymakers have tried countless
Read More

Potential of Implementing Polygenic Risk Scores in Healthcare Systems

by Dr George Busby, co-founder and Chief Scientific Officer at Allelica 04/06/2022 Leave a Comment

Challenges and Potential of Implementing Polygenic Risk Scores in US Healthcare Systems

The promise of personalized medicine is a world in which interventions, screening, and therapeutics are targeted to those most likely to get the disease. Polygenic risk scores will help society reach this ambition by accurately assessing the contribution that one’s DNA makes to disease risk.  When Thomas Jefferson wrote in the Declaration of Independence that ‘all men are created equal,’ he captured the essential concept of equality on which the US Constitution is based. Although no one would
Read More

COTA Promotes Miruna Sasu to President and CEO

by Digital Health Executive Appointments 03/24/2022 Leave a Comment

COTA Promotes Miruna Sasu to President and CEO

What You Should Know: - COTA, Inc., an oncology real-world data and analytics company, announced today that Miruna Sasu, Ph.D., MBA, has been appointed president and chief executive officer.  - Since April 2021 when she was hired as the company’s chief strategy officer, Miruna has helped spearhead a series of research collaborations focused on investigating racial disparities in cancer care and the drug development process, including partnerships with the University of Chicago
Read More

Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration

by HIMSS22 Summary 03/16/2022 Leave a Comment

HIMSS22 Day 2 Roundup: Google Partners with MEDITECH, Microsoft’s Health Cloud Strategy Expansions,

Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More

To Advance Health Equity, Put Real-World Cancer Data to Work

by Dr. Robert S. Miller, Medical Director of CancerLinQ 03/26/2021 Leave a Comment

To Advance Health Equity, Put Real-World Cancer Data to Work

Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care. With multiple drivers of
Read More

Johnson & Johnson Innovation Launches 3 Collaborations to Advance Healthcare in China

by Fred Pennic 11/06/2020 Leave a Comment

Johnson & Johnson Innovation Launches 3 Collaborations to Advance Healthcare in China

What You Should Know: - Johnson & Johnson Innovation announces three strategic collaborations with a focus on advancing healthcare solutions in China. - The three strategic collaborations are focused on leveraging advances in science and technology to address areas of high unmet medical need across several areas, including discovery science, lung cancer, and medical devices Johnson & Johnson Innovation, a division of Johnson & Johnson (China) Investment Limited, today
Read More

Innovative Technologies Are the Future of Respiratory Care and Treatment

by HITC Staff 10/13/2020 Leave a Comment

Innovative Technologies Are the Future of Respiratory Care and Treatment

Breath measuring algorithms, smart inhalers, and wearable analytics are at the forefront of respiratory care technology. Lung cancers, including mesothelioma and asthma, account for 70% of the country’s breathing issues. Technological advancements are making it easier for specialists to diagnose and patients to administer self-care. As the COVID-19 pandemic rages forward, the advancement of pulmonary technology has gotten a boost. There is no way for the medical field to prepare for the
Read More

Philips Launches Advanced 3D Imaging Navigation Platform for Faster Lung Cancer Diagnosis

by Fred Pennic 09/21/2020 Leave a Comment

advanced 3D imaging and navigation platform

What You Should Know: - Philips paves the way for faster lung cancer diagnosis and treatment with advanced 3D imaging and navigation platform with the launch of Azurion Lung Edition. - By speeding diagnosis and treatment, Azurion Lung Edition is helping to transform lung cancer care, contributing to dramatically improved outcomes and reduced costs. Royal Philips, today announced the launch of Azurion Lung Edition, an advanced 3D imaging and navigation platform to accelerate the
Read More

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

by Fred Pennic 05/28/2020 Leave a Comment

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

What You Should Know: - Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine. - Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine. Syapse, a San Francisco, CA-based provider of precision oncology solutions announced $30
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards

Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |